Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ M}u1qXa
"9%qbMB
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© o(zTNk5d
ydB$4ZB3[
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© EavX8r
|
_, /u_
1.Co-stimulators (or co-stimulating molecules) G0pBR]_5z$
L_k9g12
2.NK-kB Qm; BUG]
NHAH#7]M&1
3.Immunoglobulin superfamily GkciA{
St2Q7K5s{
4.antigen-presenting cell (APC) K#wK1 Sv
aHC%19UN
5.death domain 8kS~ENe?o
ami09JHy
6.CCR and CXCR P5Dk63z]
7`dY 1.rq
7.Lectin (or mitogen) kW+G1|
tt{`\1q
8.Clusters of differentiation, CD) "wINBya'M
`m, Ki69.
9.B7 family M(2`2-/xh
Yf=FeH7"
10.Cytotoxic T lymphocyte, CTL) n`.#59-Hx
H(&Z:{L
11.IL-15 and IL-15 receptor (IL-15R) {(Fe7,.S3
lkwh'@s.
12.MHC restriction GO~k '
#KE;=$(S
13.Affinity-chromatography n| C|&
&D*8l?A/1f
14.Cyctosprin A, CsA Q.ukY@L.'
0Cq!\nzz
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 8t[t{"
U&Ab#m;
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 6#|qg*
OS
;"@ :}_t
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 (Oq Hfv
Rcf=J){D6
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ [%~^kq=|
WHk/$7_"i
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ OZT^\Ky_l
@yKZRwg
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© p8>R#9
qiU5{}
ÃâÒßѧרҵ£º BSDk9Oc
B1+ZFQo
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Yrsp%<qj
4=s9A
Ïû»¯ÄÚ¿Æ£º S.hC$0vrj
n;qz^HXEJ
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ $}4K
`Iu
4|F#gK5E
ѪҺ²¡Ñ§×¨Òµ£º @G(xaU'u
9FNwpL'C
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿